1240 – 666 Burrard Street
Member Sector: Biopharmaceuticals
Eupraxia Pharmaceuticals Inc., through research and development and a collaboration of expert’s within the medical field (both individuals and enterprise), is discovering, developing, and plans to market innovative technologies for some of society’s most prevalent diseases. The Company is advancing the development of a wide portfolio of potential drug and drug delivery system opportunities. Eupraxia intends to provide and continue to build value to its shareholders and to society through the development and marketing of its revolutionary drug and drug delivery platform combination developed in cooperation with its joint venture partner. By joining forces with a company that has a successful history of getting drugs to market Eupraxia is increasing value to shareholders by decreasing risk and making the trajectory of getting the drug to patients more linear and faster. Our motto is our driving force behind all we do; working to provide relief to millions.